🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.615.172

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 2 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
12/05/2015 0,7900 USD
10/02/2015 0,7900 USD
10/11/2014 0,6100 USD
12/08/2014 0,6100 USD
13/05/2014 0,6100 USD
11/02/2014 0,6100 USD
12/11/2013 0,4700 USD
14/08/2013 0,4700 USD
14/05/2013 0,4700 USD
11/02/2013 0,4700 USD
13/11/2012 0,3600 USD
14/08/2012 0,3600 USD
14/05/2012 0,3600 USD
13/02/2012 0,3600 USD
15/11/2011 0,2800 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/06/2017 173,02 173,92 170,77 170,85 -1,62% 1,82% 2.941.500
26/06/2017 173,39 174,72 172,41 173,67 +0,68% 1,33% 3.037.600
23/06/2017 173,24 174,13 170,96 172,50 -0,76% 1,83% 14.368.500
22/06/2017 172,44 175,45 172,10 173,82 +1,44% 1,94% 5.745.800
21/06/2017 167,20 171,76 166,36 171,35 +3,04% 3,23% 5.490.800
20/06/2017 165,43 168,70 164,79 166,29 +0,73% 2,36% 3.857.900
19/06/2017 163,10 165,22 162,69 165,09 +1,64% 1,55% 3.043.900
16/06/2017 163,84 164,10 161,13 162,42 -1,03% 1,81% 5.887.200
15/06/2017 164,24 164,90 162,55 164,11 -0,60% 1,43% 3.585.000
14/06/2017 164,36 165,88 163,97 165,10 +0,41% 1,16% 2.594.800
13/06/2017 164,47 165,09 163,77 164,43 -0,27% 0,80% 2.568.200
12/06/2017 165,00 167,23 163,28 164,88 +0,50% 2,39% 4.344.500
09/06/2017 162,75 166,14 162,63 164,06 +0,87% 2,16% 4.086.800
08/06/2017 161,98 163,17 161,41 162,65 +0,61% 1,09% 3.555.100
07/06/2017 159,82 162,05 159,75 161,66 +1,34% 1,44% 3.571.500
06/06/2017 160,13 160,92 159,24 159,53 -0,43% 1,05% 3.002.500
05/06/2017 160,29 161,12 158,27 160,22 +0,67% 1,78% 4.611.100
02/06/2017 157,27 159,62 157,00 159,15 +1,86% 1,67% 3.320.800
01/06/2017 155,40 156,77 155,24 156,24 +0,64% 0,98% 3.005.300
31/05/2017 153,67 155,37 153,67 155,24 +0,90% 1,11% 3.891.300
30/05/2017 155,01 155,37 153,56 153,85 -0,75% 1,17% 2.716.700
26/05/2017 155,60 156,13 154,79 155,01 -0,27% 0,86% 2.731.600
25/05/2017 155,19 156,04 154,62 155,43 +0,54% 0,92% 2.965.800
24/05/2017 154,77 154,99 153,79 154,60 +0,34% 0,78% 2.667.500
23/05/2017 152,65 154,57 152,16 154,07 +0,69% 1,58% 3.582.000
22/05/2017 153,59 154,60 152,45 153,02 -2,23% 1,40% 6.911.700
19/05/2017 157,59 158,58 156,35 156,51 -0,92% 1,42% 2.577.300
18/05/2017 157,37 158,79 156,29 157,96 +0,57% 1,59% 2.163.300
17/05/2017 158,77 159,29 156,93 157,06 -1,83% 1,49% 3.073.200
16/05/2017 159,77 160,49 159,46 159,99 +0,01% 0,64% 2.281.200